2019-A00745-52

About this trial

Last updated 6 years ago

Study ID

2019-A00745-52

Status

Unknown status

Type

Interventional

Phase

N/A

Placebo

Accepting

18+ Years

All

Trial Timing

Ended 4 years ago

The NOMADE study has a dual purpose: - Test the performance of new types of sensors that are likely to integrate Bioserenity devices and will therefore improve them. - Test the performance of the sensors of Bioserenity CE devices and their advanced versions Different EC and non-CE models of Neuronaute and Cardioskin may be tested in this study.

Inclusion Criteria

- Male, female at least 18 years

- Membership of a social security scheme

Exclusion Criteria

- Minors

- Refusal of consent

- Allergy to one of the components of Bioserenity products, including:Polyamide (other polymers),Polyester,Elasthanne,Polyethylene/polyopropylene (other polymers),Titanium,Silicone,Silver/Copper,Other synthetic materials

- Allergy to one of the components present in commercial electrodes (gel electrode type Kendall 530 or similar; or electrodes type Ag/Agcl; or other electrodes containing in particular: acrylate/polyacrylate, acrylic acid, Impedimed electrodes, etc.)

- Allergy to one of the components in an electroconductive cream for sensors (Elefix, Ten20 and similar biocompatible product)

- Known allergy to one of the components in a commercial EEG helmet (neoprene, elastomer, silicone, etc.)

- Sensory disorders that make the participant insensitive to pain

- Motor or mental disorders that prevent the participant from expressing pain

- Behavioural disorders that make the participant excessively agitated or aggressive

- Person protected

evaluatioN de la perfOrMAnce De Capteurs E-textiles